Perfusionist

LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE Mark

Retrieved on: 
Wednesday, August 30, 2023

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark for its Essenz™ In-Line Blood Monitor (ILBM), which provides accurate and continuous measurement of essential blood parameters to perfusionists throughout cardiopulmonary bypass (CPB) procedures.

Key Points: 
  • LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance and CE Mark for its Essenz™ In-Line Blood Monitor (ILBM), which provides accurate and continuous measurement of essential blood parameters to perfusionists throughout cardiopulmonary bypass (CPB) procedures.
  • “Dynamic conditions can rapidly change a patient’s blood parameters during a cardiopulmonary bypass procedure,” said Marco Dolci, LivaNova President, Cardiopulmonary.
  • “The Essenz In-Line Blood Monitor provides continuous monitoring throughout a patient’s procedure.
  • It consists of a next-generation heart-lung machine (HLM), a patient monitor and accurate sensing technology that now includes the ILBM.

LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures

Retrieved on: 
Thursday, March 9, 2023

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™ Heart-Lung Machine (HLM).

Key Points: 
  • LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Essenz™ Heart-Lung Machine (HLM).
  • With FDA clearance, LivaNova initiates the commercial launch of Essenz in the U.S.
  • The Essenz HLM and Essenz™ Patient Monitor comprise the Essenz™ Perfusion System, which enables a patient-tailored perfusion approach rooted in data-driven decisions that improve both clinical workflows and quality of patient care during cardiopulmonary bypass (CPB) procedures.
  • Key attributes of the Essenz Perfusion System include:
    The system is built on the proven LivaNova S5™ HLM, which has supported millions of patients for safe CPB procedures.

LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures

Retrieved on: 
Wednesday, February 8, 2023

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion System*.

Key Points: 
  • LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the start of a limited commercial release for the Essenz™ Perfusion System*.
  • View the full release here: https://www.businesswire.com/news/home/20230208005127/en/
    LivaNova's Essenz™ Perfusion System (Photo: Business Wire)
    Catharina Hospital was the first hospital in the world to carry out clinical cases with the Essenz Perfusion System.
  • The Essenz Perfusion System features an ergonomic design, including advanced cable management and a mast-mounted design to keep the area clean and hygienic.
  • Learn more about the Essenz Perfusion System and Essenz Patient Monitor on the LivaNova website.

For the 4th Year in a Row, Keystone Perfusion Services Ranks on the Inc. 5000 List of America's Fastest-Growing Companies

Retrieved on: 
Tuesday, August 16, 2022

1,541 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America.

Key Points: 
  • 1,541 on its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America.
  • The list represents a one-of-a-kind look at the most successful companies within the economy's most dynamic segmentits independent businesses.
  • This is the fourth year in a row that Keystone Perfusion ranked on the Inc. 5000 list, making it one of only a fraction of companies that have made the list more than once.
  • The hospitals and health systems we serve have come to expect the highest quality of services and specialists from Keystone Perfusion."

AirECMO and REVA launch cooperation

Retrieved on: 
Thursday, August 4, 2022

PHILADELPHIA, Aug. 4, 2022 /PRNewswire/ -- AirECMO, Inc., a division of Keystone Perfusion Services, P.C.

Key Points: 
  • PHILADELPHIA, Aug. 4, 2022 /PRNewswire/ -- AirECMO, Inc., a division of Keystone Perfusion Services, P.C.
  • announces a strategic partnership with industry leading air ambulance provider, REVA, to provide ECMO transportation capabilities globally.
  • AirECMO announces a strategic partnership with REVA to provide ECMO transportation capabilities globally.
  • www.airecmo.com
    About REVA REVA, Inc., owner-operators of a fleet of 16 medically configured aircraft, including small and mid-size jets, employs over 350 air-ambulance-service professionals who deliver caring, efficient, fully-accredited medical care from bases throughout North America, including the Caribbean.

Vesey Street Capital Partners Announces Gus Gardner as Chief Executive Officer of QualityMetric

Retrieved on: 
Friday, September 11, 2020

Martha Bayliss to become Advisor, added with Gardner to company Board of Directors

Key Points: 
  • Martha Bayliss to become Advisor, added with Gardner to company Board of Directors
    NEW YORK, Sept. 11, 2020 (GLOBE NEWSWIRE) -- QualityMetric ("QM"), an industry-leader of patient reported outcomes and clinical outcomes assessments products, scientific consulting and translation services, announced today the appointment of Garth Gus Gardner as Chief Executive Officer.
  • Were very excited about this announcement from Vesey Street Capital Partners newest portfolio company and we look forward to partnering with Gus and the executive team on future growth opportunities, said Adam Feinstein, Managing Partner at VSCP.
  • Mr. Gardner is a formerly Board Certified Cardiovascular Perfusionist, and began his leadership career as an Officer in the United States Marine Corps.
  • Since inception, the firm has deployed approximately $600 million in capital, primarily as a control investor.

Bioxytran Guest Speaker on Perfusionists Continuing Education Program Discussing Acute Respiratory Distress Syndrome and Ways to Combat COVID-19

Retrieved on: 
Thursday, March 12, 2020

The perfusion education program is essentially a community gathering place where members can be informed of evidence-based advancements in the field of perfusion.

Key Points: 
  • The perfusion education program is essentially a community gathering place where members can be informed of evidence-based advancements in the field of perfusion.
  • There are about 10,000 registered users that use this forum as continuing education credit.
  • The channel seeks to provide continuing education content that is interesting and informs and educates perfusionists on the latest advances and findings in the field of perfusion.
  • In the future, perfusionists could utilize the MDX Viewer in conjunction with Extracorporeal Membrane Oxygenation (ECMO) therapy on end stage ARDS patients.